The Metabolic Syndrome, Insulin Resistance, and Cardiovascular Risk in Diabetic and Nondiabetic Patients | Zendy

Christoph H. Saely | Zendy; Stefan Aczél | Zendy; Thomas Marte | Zendy; P. Langer | Zendy; Guenter Hoefle | Zendy; Heinz Drexel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Metabolic Syndrome, Insulin Resistance, and Cardiovascular Risk in Diabetic and Nondiabetic Patients

Author(s) -

Christoph H. Saely,

Stefan Aczél,

Thomas Marte,

P. Langer,

Guenter Hoefle,

Heinz Drexel

Publication year - 2005

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2005-0799

Subject(s) - insulin resistance , medicine , metabolic syndrome , hazard ratio , vascular resistance , diabetes mellitus , coronary artery disease , prospective cohort study , type 2 diabetes , confidence interval , incidence (geometry) , insulin , endocrinology , cardiology , blood pressure , physics , optics

The contribution of insulin resistance per se to the vascular risk conferred by the metabolic syndrome (MetS) is not known; conversely, it is uncertain whether insulin resistance confers vascular risk beyond the entity of the MetS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research